P, S., M, M., G, C., W, G., C, T., R, L., . . . JH, T. (2022). Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency. The New England journal of medicine, 387(6), 514. https://doi.org/10.1056/NEJMoa2205416
Chicago Style (17th ed.) CitationP, Strnad, et al. "Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency." The New England Journal of Medicine 387, no. 6 (2022): 514. https://doi.org/10.1056/NEJMoa2205416.
MLA (9th ed.) CitationP, Strnad, et al. "Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency." The New England Journal of Medicine, vol. 387, no. 6, 2022, p. 514, https://doi.org/10.1056/NEJMoa2205416.
Warning: These citations may not always be 100% accurate.